Scinai Immunotherapeutics (SCNI) Receivables - Net (2015 - 2026)
Scinai Immunotherapeutics (SCNI) posted Receivables - Net of $150.0 million for Q1 2026, up 105.48% sequentially from $73.0 million in Q4 2025.
Scinai Immunotherapeutics (SCNI) Receivables - Net (2015 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Receivables - Net for 12 years, with the latest figure at $150.0 million in Q1 2026.
- Quarterly Receivables - Net changed N/A year-over-year to $150.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $150.0 million (changed N/A YoY) and the FY2025 annual result came in at $73.0 million, up 87851.81% from the prior year.
- Receivables - Net rose to $150.0 million in Q1 2026 per SCNI's latest filing, from $73.0 million in the prior quarter.
- Over five years, Receivables - Net peaked at $150.0 million in Q1 2026 and troughed at $83000.0 in Q4 2024.
- A 5-year average of $20.9 million and a median of $179000.0 in 2022 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2022 and 2025: Receivables - Net tumbled 99.99% in 2022, then jumped 87851.81% in 2025.
- Over 5 years, Receivables - Net stood at $202000.0 in 2022, then declined by 24.75% to $152000.0 in 2023, then sank by 45.39% to $83000.0 in 2024, then surged by 87851.81% to $73.0 million in 2025, then soared by 105.48% to $150.0 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $150.0 million, $73.0 million, and $139000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | Scinai Immunotherapeutics | 11.09 Mn | -3.10 Bn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150.00 Mn |
| Mar 31, 2026 | 150.00 Mn |
| Dec 31, 2025 | 73.00 Mn |
| Dec 31, 2025 | 73.00 Mn |
| Jun 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Dec 31, 2024 | 83,000.00 |
| Dec 31, 2024 | 83,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Jun 30, 2024 | 119,000.00 |
| Jun 30, 2024 | 119,000.00 |
| Dec 31, 2023 | 152,000.00 |
| Dec 31, 2023 | 152,000.00 |
| Jun 30, 2023 | 5.83 Mn |
| Jun 30, 2023 | 5.83 Mn |
| Sep 30, 2022 | 202,000.00 |
| Sep 30, 2022 | 202,000.00 |
| Jun 30, 2022 | 179,000.00 |
| Jun 30, 2022 | 179,000.00 |